Related references
Note: Only part of the references are listed.A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
Lynn E. Connolly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vivo Efficacy of Plazomicin Alone or in Combination with Meropenem or Tigecycline against Enterobacteriaceae Isolates Exhibiting Various Resistance Mechanisms in an Immunocompetent Murine Septicemia Model
Kamilia Abdelraouf et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers
Andreza Francisco Martins et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2018)
In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents
Maria Carmen Lopez Diaz et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates
Valerie Denervaud-Tendon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Amikacin: Uses, Resistance, and Prospects for Inhibition
Maria S. Ramirez et al.
MOLECULES (2017)
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group
Yohei Doi et al.
CLINICAL INFECTIOUS DISEASES (2017)
New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance
Ling-Shan Syue et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains
Iciar Rodriguez-Avial et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp.
Steven C. Olsen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram- Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
A. Walkty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model
George Louis Drusano et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Telemetry used to determine efficacy of intravenous plazomicin against inhaled tularemia in cynomolgus macaques (CM)
Kristy Bruse et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2014)
Antibiotics in development targeting protein synthesis
Joyce A. Sutcliffe
ANTIMICROBIAL THERAPEUTICS REVIEWS: ANTIBIOTICS THAT TARGET THE RIBOSOME (2011)
Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
Robert T. Cass et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vivo Efficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models
Noe Reyes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals
Fred C. Tenover et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
D. M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation
R. Colby Layton et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2011)
Synthesis and Spectrum of the Neoglycoside ACHN-490
James B. Aggen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The Future of Aminoglycosides: The End or Renaissance?
Jacob L. Houghton et al.
CHEMBIOCHEM (2010)
Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections
Anjali N. Kunz et al.
CHEMOTHERAPY (2010)
Combating evolution with intelligent design: the neoglycoside ACHN-490
Eliana S. Armstrong et al.
CURRENT OPINION IN MICROBIOLOGY (2010)
New aminoglycoside antibiotics
Paola Dozzo et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
David Landman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)